Mild-to-moderate renal pelvis dilatation identified during pregnancy and hospital admissions in childhood: An electronic birth cohort study in Wales, UK.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
07 2019
Historique:
received: 04 12 2018
accepted: 21 06 2019
entrez: 31 7 2019
pubmed: 31 7 2019
medline: 20 12 2019
Statut: epublish

Résumé

Chronic kidney disease (CKD) is a growing contributor to the global burden of noncommunicable diseases. Early diagnosis and treatment can reduce the severity of kidney damage and the need for dialysis or transplantation. It is not known whether mild-to-moderate renal pelvis dilatation (RPD) identified at 18-20 weeks gestation is an early indicator of renal pathology. The aim of this follow-up to the Welsh Study of Mothers and Babies was to assess the risk of hospital admission in children with mild-to-moderate antenatal RPD compared with children without this finding. We also examined how the natural history of the RPD (whether the dilatation persists in later pregnancy or postpartum) or its characteristics (unilateral versus bilateral) changed the risk of hospital admission. This population-based cohort study included singleton babies born in Wales between January 1, 2009, and December 31, 2011 (n = 22,045). We linked ultrasound scan data to routinely available data on hospital admissions from the Patient Episode Database for Wales (PEDW). The outcome was a hospital admission for urinary tract causes (defined by an expert study steering group) in the first three years of life. We used Cox regression to model time to first hospital admission, according to whether there was evidence of RPD at the fetal anomaly scan (FAS) and/or evidence of dilatation in later investigations, adjusting for other predictors of admission. We used multiple imputation with chained equations to impute values for missing data. We included 21,239 children in the analysis. The risk of at least one hospital admission was seven times greater in those with RPD (n = 138) compared with those without (n = 21,101, conditional hazard ratio [cHR] 7.23, 95% confidence interval [CI] 4.31-12.15, p < 0.001). The risk of hospital admission was higher in children with RPD at the FAS and later dilatation (cHR 25.13, 95% CI 13.26-47.64, p < 0.001) and in children without RPD at the FAS who had later dilatation (cHR 62.06, 95% CI 41.10-93.71, p < 0.001) than in children without RPD (n = 21,057). Among children with RPD at the FAS but no dilatation in later pregnancy or postpartum, we did not find an association with hospital admissions (cHR 2.16, 95% CI 0.69-6.75, p = 0.185), except when the initial dilatation was bilateral (cHR 4.77, 95% CI 1.17-19.47, p = 0.029). Limitations of the study include small numbers in subgroups (meaning that these results should be interpreted with caution), that less severe outcomes (such as urinary tract infections [UTIs] managed in the community or in outpatients) could not be included in our analysis, and that obtaining records of radiological investigations later in pregnancy and postpartum was challenging. Our conclusions were consistent after conducting sensitivity analyses to account for some of these limitations. In this large population-based study, children with RPD at the FAS had higher rates of hospital admissions when there was persistent dilatation in later pregnancy or postpartum. Our results can be used to improve counselling of parents and develop care pathways for antenatal screening programmes, including protocols for reporting and further investigation of RPD.

Sections du résumé

BACKGROUND
Chronic kidney disease (CKD) is a growing contributor to the global burden of noncommunicable diseases. Early diagnosis and treatment can reduce the severity of kidney damage and the need for dialysis or transplantation. It is not known whether mild-to-moderate renal pelvis dilatation (RPD) identified at 18-20 weeks gestation is an early indicator of renal pathology. The aim of this follow-up to the Welsh Study of Mothers and Babies was to assess the risk of hospital admission in children with mild-to-moderate antenatal RPD compared with children without this finding. We also examined how the natural history of the RPD (whether the dilatation persists in later pregnancy or postpartum) or its characteristics (unilateral versus bilateral) changed the risk of hospital admission.
METHODS/FINDINGS
This population-based cohort study included singleton babies born in Wales between January 1, 2009, and December 31, 2011 (n = 22,045). We linked ultrasound scan data to routinely available data on hospital admissions from the Patient Episode Database for Wales (PEDW). The outcome was a hospital admission for urinary tract causes (defined by an expert study steering group) in the first three years of life. We used Cox regression to model time to first hospital admission, according to whether there was evidence of RPD at the fetal anomaly scan (FAS) and/or evidence of dilatation in later investigations, adjusting for other predictors of admission. We used multiple imputation with chained equations to impute values for missing data. We included 21,239 children in the analysis. The risk of at least one hospital admission was seven times greater in those with RPD (n = 138) compared with those without (n = 21,101, conditional hazard ratio [cHR] 7.23, 95% confidence interval [CI] 4.31-12.15, p < 0.001). The risk of hospital admission was higher in children with RPD at the FAS and later dilatation (cHR 25.13, 95% CI 13.26-47.64, p < 0.001) and in children without RPD at the FAS who had later dilatation (cHR 62.06, 95% CI 41.10-93.71, p < 0.001) than in children without RPD (n = 21,057). Among children with RPD at the FAS but no dilatation in later pregnancy or postpartum, we did not find an association with hospital admissions (cHR 2.16, 95% CI 0.69-6.75, p = 0.185), except when the initial dilatation was bilateral (cHR 4.77, 95% CI 1.17-19.47, p = 0.029). Limitations of the study include small numbers in subgroups (meaning that these results should be interpreted with caution), that less severe outcomes (such as urinary tract infections [UTIs] managed in the community or in outpatients) could not be included in our analysis, and that obtaining records of radiological investigations later in pregnancy and postpartum was challenging. Our conclusions were consistent after conducting sensitivity analyses to account for some of these limitations.
CONCLUSIONS
In this large population-based study, children with RPD at the FAS had higher rates of hospital admissions when there was persistent dilatation in later pregnancy or postpartum. Our results can be used to improve counselling of parents and develop care pathways for antenatal screening programmes, including protocols for reporting and further investigation of RPD.

Identifiants

pubmed: 31361739
doi: 10.1371/journal.pmed.1002859
pii: PMEDICINE-D-18-04213
pmc: PMC6667131
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1002859

Subventions

Organisme : Medical Research Council
ID : RFSH07340
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Matern Fetal Neonatal Med. 2016;29(15):2494-9
pubmed: 26430907
J Urol. 2008 Jan;179(1):284-9
pubmed: 18001783
Eur J Pediatr. 2016 May;175(5):667-76
pubmed: 26805407
BMC Med Inform Decis Mak. 2009 Jan 16;9:3
pubmed: 19149883
Lancet. 2005 Feb 12-18;365(9459):579-87
pubmed: 15708101
Urology. 2007 May;69(5):970-4
pubmed: 17482945
J Pediatr Urol. 2017 Oct;13(5):485.e1-485.e7
pubmed: 28499796
Urology. 2014 Apr;83(4):909-14
pubmed: 24411215
Curr Urol Rep. 2014 Aug;15(8):430
pubmed: 24927968
Eur J Obstet Gynecol Reprod Biol. 2005 Feb 1;118(2):154-9
pubmed: 15653195
Ultrasound Obstet Gynecol. 2007 Apr;29(4):463-9
pubmed: 17390310
J Pediatr Urol. 2014 Dec;10(6):982-98
pubmed: 25435247
Pediatr Nephrol. 2011 Mar;26(3):353-64
pubmed: 20798957
Prenat Diagn. 2016 Jan;36(1):40-8
pubmed: 26475362
J Pediatr Urol. 2017 Jun;13(3):316.e1-316.e5
pubmed: 28215834
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Pediatrics. 2013 Jan;131(1):e251-61
pubmed: 23248229
Pediatr Nephrol. 2007 Dec;22(12):1999-2009
pubmed: 17310363
J Urol. 2016 Mar;195(3):725-30
pubmed: 26527513
J Urol. 2015 May;193(5 Suppl):1766-71
pubmed: 25813560
J Pediatr Urol. 2009 Feb;5(1):47-52
pubmed: 18977697
Stat Med. 2009 Jul 10;28(15):1982-98
pubmed: 19452569
J Pediatr Urol. 2014 Aug;10(4):650-4
pubmed: 25155409
Pediatr Nephrol. 2012 Mar;27(3):363-73
pubmed: 21713524
Prenat Diagn. 1999 Aug;19(8):701-5
pubmed: 10451511
BMC Pregnancy Childbirth. 2014 May 08;14:164
pubmed: 24884594
Clin J Am Soc Nephrol. 2009 Jan;4(1):168-77
pubmed: 18987299
BMC Health Serv Res. 2009 Sep 04;9:157
pubmed: 19732426
Eur Urol. 2005 Aug;48(2):207-14
pubmed: 16005373
Pediatrics. 2006 Aug;118(2):586-93
pubmed: 16882811
Pediatr Radiol. 2017 Aug;47(9):1109-1115
pubmed: 28779200
J Pediatr Urol. 2010 Jun;6(3):212-31
pubmed: 20399145
Arch Dis Child Fetal Neonatal Ed. 2015 Sep;100(5):F460-4
pubmed: 25605618
Kidney Int. 2011 Dec;80(12):1258-70
pubmed: 21993585
Pediatr Nephrol. 2014 Jul;29(7):1169-74
pubmed: 23963710
J Urol. 2012 Nov;188(5):1935-9
pubmed: 22999539
Curr Opin Pediatr. 2016 Apr;28(2):195-201
pubmed: 26807623

Auteurs

Lisa Hurt (L)

Division of Population Medicine, Cardiff University School of Medicine, Cardiff, United Kingdom.

Melissa Wright (M)

Centre for Trials Research, Cardiff University, Cardiff, United Kingdom.

Joanne Demmler (J)

Swansea University Medical School, Swansea, United Kingdom.

Judith VanDerVoort (J)

Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom.

Susan Morris (S)

Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom.

Fiona Brook (F)

Aneurin Bevan University Health Board, Caerleon, Newport, United Kingdom.

David Tucker (D)

Congenital Anomaly Register and Information Service, Singleton Hospital, Swansea, United Kingdom.

Maria Chapman (M)

Antenatal Screening Wales, Public Health Wales, Cardiff, United Kingdom.

Nick A Francis (NA)

Division of Population Medicine, Cardiff University School of Medicine, Cardiff, United Kingdom.

Rhian Daniel (R)

Division of Population Medicine, Cardiff University School of Medicine, Cardiff, United Kingdom.

David Fone (D)

Division of Population Medicine, Cardiff University School of Medicine, Cardiff, United Kingdom.

Sinead Brophy (S)

Centre for Trials Research, Cardiff University, Cardiff, United Kingdom.

Shantini Paranjothy (S)

Division of Population Medicine, Cardiff University School of Medicine, Cardiff, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH